D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.

There was a 9.7% rise in anti-social behaviour incidents in the 12 months to September logged by Cleveland Police ...